Gratus Capital LLC Astrazeneca PLC Transaction History

Gratus Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$53.02 - $135.75 $6,892 - $17,647	130 Added 3.64%	3,702 $203,000
Q4 2021 Jan 31, 2022	BUY	$54.02 - $63.83 $192,959 - $228,000	3,572 New	3,572 $208,000
Q4 2020 Feb 03, 2021	SELL	$48.52 - $58.02 $6.05 Million - $7.24 Million	-124,752 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$53.07 - $61.1 $737,195 - $848,740	-13,891 Reduced 10.02%	124,752 $6.84 Million
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $5.98 Million - $7.67 Million	138,643 New	138,643 $7.33 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Gratus Capital LLC with notifications on news.